← feed

Is NCT03178422 results overdue?

Yes — results are overdue. Primary completion was 2017-10-18; the FDAAA-801 reporting deadline (2018-10-18) passed 2803 days ago and no results are posted on ClinicalTrials.gov.

Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects

NCT IDNCT03178422 ↗
SponsorChrono Therapeutics, Inc. (INDUSTRY)
PhasePHASE2
StatusCOMPLETED
Primary completion2017-10-18 (ACTUAL)
Reporting deadline2018-10-18 (completion + 365d)
Days overdue2803
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 25d9d9276906d0da… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03178422. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →